Co-culture of probiotic bacteria for growth factor delivery in minigut organoids
Co-culture of probiotic bacteria for growth factor delivery in minigut organoids
批准号:
9789051
负责人:
Thomas J Mansell
金额:
$17.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-20 至 2020-07-31
关键词:
3-DimensionalAnimal ExperimentsAnimal ModelBacteriaBehaviorBiological ModelsBiosensorButyratesCell Culture TechniquesCell Differentiation processCell LineCell divisionCell physiologyCell secretionCellsChloride IonChloridesChronic DiseaseCoculture TechniquesCommunicationDetectionDevelopmentDiabetes MellitusDifferentiation AntigensEngineered ProbioticsEngineeringEnterocytesEnteroendocrine CellEnvironmentEpithelial CellsEscherichia coliFluorescence MicroscopyGene ExpressionGenesGeneticGnotobioticGoalsGoldGrowthGrowth FactorHarvestHeartHormonalImageImageryInflammatory Bowel DiseasesIntestinal SecretionsIntestinesKnowledgeLabelMetabolic syndromeModelingMolecularMonitorOrganoidsOutcomeOutputPathway interactionsPeptidesPhenotypePhysiologyProbioticsProductionProtein SecretionProteinsRegulationResourcesSerotoninSignal TransductionStem cellsTechnologyTestingTherapeuticTimeTime Studybasecell growthcell typecommensal bacteriacostcytokinedesignexperimental studygut bacteriagut microbiotahost-microbe interactionshuman diseaseimprovedintestinal cryptintestinal villimicrobialpathogenpathogenic bacteriaphysical chemical interactionpublic health relevanceresponsesmall moleculethree dimensional cell culturetranslational impact
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Interactions between gut bacteria and intestinal cells have been implicated in many human
diseases including inflammatory bowel disease, diabetes,metabolic syndrome, and many more.
Currently, gnotobiotic animal models are the gold standard for testing and understanding these
interactions, but animal experiments are costly and gnotibiotic colonies require large amounts of
resources. We propose that cultured intestinal organoids or "miniguts" can be used as an
intermediate environment in whichbacteria can be cultured and the effect of bacterial culture
and secretion on mammalian gene expression can be monitored at relatively shorter times and
lower costs. Our approach is to co-culture engineered probiotic bacteria to accurately monitor
and actively influence the development of intestinal epithelial cells in 3D culture.
We propose to develop this technology via the following Specific Aims:
Aim 1: Establish real-time phenotypic characterization of cell differentiation in miniguts
by engineered whole-cell biosensors. We will develop whole cell biosensors for intestinal
secretions such as chloride and serotonin using engineered probiotic E. coli bacteria. The
rationale behind this aim is that secretion of these molecules is an indication of proper
differentiation of intestinal stem cells into distinct cell types. The biosensor with fluorescent
output will operate in real-time which will allow dynamic visualization of secretion phenotypes by
fluorescence microscopy.
Aim 2: Alter minigut growth by secretion of small molecules and growth factors from
commensal bacteria. We will engineer probiotic bacteria to deliver molecules that negatively
and positively influence the proliferation of stem cells in 3D culture. The rationale of this aim is
that secretion of butyrate, a key metabolite, is naturally microbially-driven in the gut and the
effect of microbial butyrate production on gut cells is profound. In addition, we wish to study
positive regulation of growth by bacterial secretion the growth factor R-spondin-1 in the minigut
lumen.
Taken together, successful implementation of these aims will develop a robust co-culture
platform for the optimization of 3D organoid cultures and the study of host-microbe interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Location-specific In Vivo Sensing and Imaging of Butyrate in the GI Tract
-
批准号:10433447
-
项目类别:
-
资助金额:$21.3万
-
财政年份:2022
-
负责人:Thomas J Mansell
-
依托单位:
Location-specific In Vivo Sensing and Imaging of Butyrate in the GI Tract
-
批准号:10611459
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2022
-
负责人:Thomas J Mansell
-
依托单位:
Creating a niche for engineered live biotherapeutics
-
批准号:10276995
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2021
-
负责人:Thomas J Mansell
-
依托单位:
Creating a niche for engineered live biotherapeutics
-
批准号:10427447
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2021
-
负责人:Thomas J Mansell
-
依托单位:
Creating a niche for engineered live biotherapeutics
-
批准号:10622534
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2021
-
负责人:Thomas J Mansell
-
依托单位:
海外基金